Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia.

J Clin Oncol · 2021 · PMC8078354 · PMID 32931398

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a trend toward significanceno p-value reported

Having a high versus low/intermediate International Prognostic Scoring System for Waldenström Macroglobulinemia score 16 (5-year PFS rate, 38% v 63%; P = .06) and age > 65 v ≤ 65 years (5-year PFS rate, 40% v 65%; P = .07) showed a trend toward significance for earlier PFS.

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.